Verastem (VSTM) Retained Earnings (2011 - 2026)
Verastem (VSTM) recorded quarterly Retained Earnings of $8.6 million in Q1 2026, up 64.81% quarter-over-quarter from $5.2 million in Q4 2025, and up 29.81% on a YoY basis from $6.6 million in Q1 2025.
Verastem (VSTM) Retained Earnings (2011 - 2026) Analysis & Trends
Verastem's Retained Earnings history runs 16 years deep, the most recent figure standing at $8.6 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 29.81% year-over-year to $8.6 million; the TTM figure through Mar 2026 stood at $8.6 million (up 29.81% YoY), while the FY2025 annual figure was $5.2 million, up 100.55% from the prior year.
- Retained Earnings was $8.6 million for Q1 2026 at Verastem, up from $5.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $8.6 million in Q1 2026 to a low of -$955.5 million in Q4 2024.
- Historically, Retained Earnings has averaged -$384.7 million across 5 years, with a median of -$130000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings surged 225.64% in 2023, then plunged 86701000.0% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$737.5 million in 2022, then slipped by 11.85% to -$824.9 million in 2023, then retreated by 15.84% to -$955.5 million in 2024, then soared by 100.55% to $5.2 million in 2025, then surged by 64.81% to $8.6 million in 2026.
- The last three Retained Earnings figures came in at $8.6 million (Q1 2026), $5.2 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 8.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.62 Mn |
| Dec 31, 2025 | 5.23 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 5.29 Mn |
| Mar 31, 2025 | 6.64 Mn |
| Dec 31, 2024 | -955.53 Mn |
| Sep 30, 2024 | -890.98 Mn |
| Jun 30, 2024 | -867.01 Mn |
| Mar 31, 2024 | -858.75 Mn |
| Dec 31, 2023 | -824.89 Mn |
| Sep 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | -753.24 Mn |
| Dec 31, 2022 | -737.52 Mn |
| Sep 30, 2022 | -39,000.00 |
| Jun 30, 2022 | -130,000.00 |
| Mar 31, 2022 | -680.67 Mn |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | -647.23 Mn |
| Jun 30, 2021 | -624.44 Mn |